Ragon Institute

What Ragon Institute does

The Ragon Institute of Mass General Brigham, MIT, and Harvard is a non-profit academic research organization founded in 2009 to harness the immune system for preventing and curing human diseases. It operates as a tri-institutional collaboration with joint faculty appointments across Mass General Brigham, MIT, and Harvard, with over 25 faculty members and more than 30 research labs organized around three thematic programs: Immune Engineering, Patient Focused Immunology, and Immunophysiology and Disease. The institute's research portfolio spans HIV vaccine development, tuberculosis, COVID-19 immunology, malaria, pregnancy immunology, and increasingly cancer immunotherapy, with notable achievements including the development of humanized mouse models for studying antibody responses, the first identification of the Omicron COVID-19 variant globally, and contributions to broadly neutralizing antibody (bNAb) therapeutics showing 83% virologic suppression at 28 weeks.

The institute's core technology infrastructure includes a state-of-the-art Biosafety Level 3 (BSL-3) laboratory, one of only eight in Massachusetts, and a centralized research services platform spanning flow cytometry, microscopy, biostatistics, single-cell RNA-sequencing, protein production, vivarium, and tissue processing. Proprietary tools include the MUNIS AI/ML epitope predictor developed by the Gaiha Lab with MIT's Jameel Clinic. The institute operates international research and outreach programs in South Africa (FRESH in Umlazi, ITEACH), Zimbabwe, Mexico, Spain, and Kenya, addressing global health inequities through longitudinal cohort studies in high-HIV-prevalence populations. It also runs educational programs including RISE (high school internships), PRISM Science Club, and the MIT HST.434 "Evolution of an Epidemic" course.

As a non-profit, Ragon's funding model relies on government research grants (primarily from NIH institutes including NIAID and NIDA), philanthropic donations from individuals and foundations (Mark and Lisa Schwartz, FEMSA, Ramón Areces Foundation, Doris Duke, Howard Hughes Medical Institute, Virginia Wellington Cabot Foundation, Cancer Research UK/NCI Cancer Grand Challenges), and institutional support from its three founding partners. The institute also generates modest fee-based revenue from BSL-3 laboratory services to external academic researchers. Its go-to-market motion is event-driven: publishing peer-reviewed research in top journals (Science, Nature, Cell, NEJM), presenting at major scientific conferences (CROI, ATI Consensus Workshop), hosting international fellowship programs, and conducting educational outreach to attract talent, collaborators, and continued funding.

Name

Ragon Institute

Legal name

Ragon Institute of Mass General Brigham, MIT, and Harvard

Website

https://ragoninstitute.org

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

251–500 employees

Short description

The Ragon Institute is a non-profit immunology research organization founded in 2009 through a collaboration of Mass General Brigham, MIT, and Harvard, focused on developing vaccines and treatments for HIV, TB, COVID-19, and cancer while training researchers and running global health programs in Sub-Saharan Africa.

Ownership category

akta.pro rank

Product category

Academic Immunology Research

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Disease-Specific Global Initiatives (HIV/TB/Malaria/NTDs) (HLAJAOAE)

akta.pro secondary industry

Immunization & Vaccine Access Partnerships (Global Vaccine Alliances) (HLAJAOAF)

Keywords

• Immunology research
• HIV vaccine development
• Infectious disease research
• Global health programs
• Academic research institute

Headquarters

HQ city

Cambridge

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations

Revenue model

1. Philanthropic Donations: As a non-profit institution, the Ragon Institute relies on generous donations from individuals, foundations, and corporations to advance its world-changing research. Donors can give to labs, outreach programs, or research programs.
2. Government Research Grants: Major funding from NIH including specific grants such as the $12 million HIPC grant for pregnancy immunology research, NIH Director's Pioneer Awards, NIDA Avenir Awards, and HIVRAD awards.
3. Cancer Grand Challenges Funding: Large-scale research funding from Cancer Grand Challenges (a partnership between Cancer Research UK and National Cancer Institute) awarded $25 million to Team MATCHMAKERS including Ragon faculty member Brandon DeKosky.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

The Ragon Institute conducts basic and translational immunology research aimed at harnessing the immune system to prevent and cure human diseases, with a primary focus on HIV vaccine development, tuberculosis, COVID-19, and malaria. It operates three thematic research programs (Immune Engineering, Patient Focused Immunology, Immunophysiology and Disease), 11 centralized research service cores, and international outreach programs (FRESH, ITEACH) in South Africa. The institute also trains researchers through fellowship and education programs (RISE, PRISM, GRASP).

Product overview

The Ragon Institute of Mass General Brigham, MIT, and Harvard is a research institution dedicated to harnessing the immune system to prevent and cure human diseases. It is not a product company; rather, it is an academic research organization that operates research programs (Program for Immune Engineering, Program for Patient Focused Immunology, Program for Immunophysiology and Disease), maintains core research facilities (including BSL-3, Flow Cytometry, Microscopy, Biostatistics, Protein Production, and others), and conducts international outreach programs (FRESH, ITEACH). The institute also supports education through fellowships and programs like RISE and PRISM. The institute has no commercial products or services for external customers.

Differentiator

Problem solved

Functional benefit

Brands

• FRESH: Females Rising Through Education, Support, and Health - a program providing counseling, testing, education, and mentorship to young at-risk women in South Africa to reduce HIV infection risk
• ITEACH
• RISE
• PRISM
• GRASP

Products and services

• Program for Immune Engineering Research program leveraging discoveries to develop cutting-edge diagnostics and treatments through immune engineering approaches. For academic researchers and clinicians.
• Program for Patient Focused Immunology Research program translating bedside observations to bench research and back, focused on patient-focused immunology worldwide. For physician-scientists and clinical researchers.
• Program for Immunophysiology and Disease Research program revealing mechanisms of immune control and disease pathogenesis to prepare for and protect against global health threats. For academic researchers and public health investigators.
• Biosafety Level 3 (BSL-3) Laboratory Services Fee-based laboratory services for external academic researchers to study dangerous pathogens including SARS-CoV-2, monkeypox, and other infectious agents. The BSL-3 team can also conduct experiments on behalf of researchers for a fee. One of only eight BSL-3 labs in Massachusetts.
• Centralized Research Services Platform Comprehensive suite of research cores including Flow Cytometry, Microscopy, Biostatistics, Cellular Immunology Database, Clinical Platform, Processing Lab, Protein Production, Scientific Editing, Tissue Platform, and Vivarium. Serving internal faculty and external academic researchers.
• FRESH (Females Rising Through Education, Support, and Health) Program providing counseling, testing, education, and mentorship to young at-risk women in the Umlazi township of KwaZulu-Natal, South Africa, to reduce HIV infection risk. For vulnerable populations in high-HIV-prevalence areas.
• ITEACH (Integration of TB in Education and Care for HIV/AIDS) Program enlisting local community leaders in South Africa to combat HIV and TB through education and care integration. For community health workers and traditional healers in disease-burdened regions.
• International Fellowship Programs Six international fellowship programs (FEMSA, Tecnológico de Monterrey, Ramón Areces Foundation, GRASP, Early Independence Fellowship, and Catherine Othieno Sempa Memorial Post Baccalaureate Scholars Program) providing stipend support for postdoctoral researchers and early-career investigators from Mexico, Spain, Africa, and other regions.
• RISE (Ragon Institute Summer Experience) Summer internship program for local high school students to explore STEM through research experiences at the Ragon Institute. For high school students in the Greater Boston community.
• PRISM Science Club Science club program for high school students from the Greater Boston community to engage with scientific research and STEM topics.
• Global Ragon-Africa Scholars Program (GRASP) Scholarship program providing up to $5,000 in travel and seed funding for Ragon-based researchers to engage with African institutions, supported by the Virginia Wellington Cabot Foundation.

Quantifiable outcome

• Major strides towards working HIV vaccine with potential to end decades-long epidemic
• +4 more outcomes

Named customers10 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

13 partnerships are on record, tiered core and major.

• Tecnológico de MonterreycoreStrategic or Co-development Partner · 2 April 2026Partnership to strengthen research ties between Mexico and the United States by building human capacity in health, science, and technology. The FEMSA Fellowship supports postdoctoral researchers from Mexico. Includes Tecnológico de Monterrey Fellowship providing three years of stipend support and FEMSA Fellowship providing one year with possibility of renewal.
• Mass General BrighamcoreStrategic or Co-development PartnerFounding institutional partner. Brings together clinicians and researchers from Mass General Brigham hospitals for collaborative immunology research and clinical translation.
• MITcoreStrategic or Co-development PartnerFounding institutional partner. MIT scientists and engineers collaborate on research, provide faculty appointments, and jointly operate educational programs like the HST.434 course.
• HarvardcoreStrategic or Co-development PartnerFounding institutional partner. Harvard Medical School faculty hold joint appointments at the Ragon Institute and collaborate on research initiatives.
• African Health Research Institute (AHRI)coreStrategic or Co-development PartnerLong-standing international research collaboration in KwaZulu-Natal, South Africa. AHRI facilities were established through collaboration with Ragon Institute, Doris Duke Foundation, and Howard Hughes Medical Institute. First institution in world to identify Omicron variant of COVID-19.
• CAPRISA (Centre for the AIDS Programme of Research in South Africa)coreStrategic or Co-development PartnerCollaboration on AIDS research and COVID-19 response in South Africa. Co-founders Dr. Salim Abdool-Karim and Quarraisha Abdool-Karim participate in educational programs and research collaborations.
• Scripps Research InstitutecoreStrategic or Co-development PartnerJoint HIV vaccine research collaboration. Scripps develops immunogen designs while Ragon provides immunobiological work using humanized mouse models. Multiple joint publications in Science and Science Immunology.
• Broad InstitutemajorTechnology or IntegrationCollaborative research on T cell proteins, tuberculosis reinfection, and nasal immunity studies. Joint studies published in Science and Nature Immunology.
• Microsoft ResearchmajorTechnology or IntegrationInnovation collaboration applying computational systems used in spam filters to HIV research. Collaboration between Microsoft Research Distinguished Scientist David Heckerman and Ragon Institute Director Bruce Walker. Honored by Computerworld.
• Harvard Global Health Institute (HGHI)majorStrategic or Co-development PartnerHGHI Visiting Research Scholars Program brings international researchers to collaborate at Harvard-affiliated institutions including Ragon. Dr. Bartholomew Ondigo selected as 2025-2026 Visiting Research Scholar.
• African Leadership AcademymajorStrategic or Co-development PartnerLong-standing collaboration bringing students from this prestigious African secondary school to participate in the HST.434 Evolution of an Epidemic course.
• Jameel Clinic at MITmajorStrategic or Co-development PartnerCollaboration on leveraging AI for vaccine development. Gaiha Lab and Professor Regina Barzilay collaborated on T cell epitope prediction.
• MIT Science and Technology Initiatives (MISTI)majorStrategic or Co-development PartnerSponsors the Evolution of an Epidemic course bringing MIT students to South Africa for hands-on global health education.

Scale indicators8 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Broad Institute of MIT and Harvard: Cambridge-based collaborative research institute involving MIT and Harvard with overlapping capabilities in genomics, infectious disease, and immunology; Ragon already partners with Broad on T cell and nasal immunity research.
• La Jolla Institute for Immunology: Non-profit research institute focused exclusively on immunology and immune system diseases, with similar core facility model and emphasis on training; comparable in scope and mission to Ragon.
• Scripps Research Institute: Non-profit biomedical research organization with overlapping HIV vaccine immunogen research and joint publications with Ragon; comparable in translational immunology focus.
• Whitehead Institute for Biomedical Research: MIT-affiliated non-profit biomedical research institute in Cambridge with similar collaborative model and faculty recruiting dynamics; comparable in Kendall Square ecosystem and scale.
• Fred Hutchinson Cancer Center: Non-profit research institution with overlapping work in cancer immunotherapy (DeKosky's Cancer Grand Challenges), HIV cure research, and large-scale grant-driven programs.
• Wistar Institute: Non-profit immunology and vaccine research institute with similar historic focus on infectious disease and HIV vaccine research; comparable in mission and grant-driven funding model.
• Institut Pasteur: International non-profit research institute with global infectious disease research network, BSL-3 capabilities, and vaccine development programs; comparable in combining basic science with global health programs.
• Allen Institute: Non-profit research institute with large-scale team science model, core facilities, and emphasis on open science; comparable in infrastructure-heavy research organization structure.
• International AIDS Vaccine Initiative (IAVI): Non-profit product development organization focused on HIV vaccine research and global health equity; directly comparable in mission, donor funding model, and global program footprint.

Others

• Howard Hughes Medical Institute: Major non-profit biomedical research funder and operator of research labs; HHMI is a current Ragon funding partner for African Health Research Institute facilities and is structurally comparable as a science funder/operator.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/ragoninstitute
• YouTubeyoutube.com/channel/UCSNPgF-QUMZ5iurul8XHZiw
• Facebookfacebook.com/208759933695
• LinkedInlinkedin.com/company/the-ragon-institute-of-mgh-mit-and-harvard
• Instagraminstagram.com/ragon_institute

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ragon Institute